Trial intelligence / Profile preview

PM012 in Alzheimer's Disease

NCT01715350Phase 2Completed

Sponsor
VTR Biotech
Start
May 2012
Primary completion
Sep 2014
Modality
Botanical Extract
Countries
1
01

Overview

A Phase 2 trial of PM012 in Alzheimer's disease (AD), sponsored by VTR Biotech. Started May 2012; status: completed.

02

Drugs

PM012
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT01715350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01715350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call